Specific interaction of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen and promotes invasion in vitro.
about
Biomarkers for the early diagnosis of hepatocellular carcinomaDNA methylation and microRNA dysregulation in cancerMolecularly and clinically related drugs and diseases are enriched in phenotypically similar drug-disease pairsA functional proteomic method for biomarker discovery.Proteomic characterization of harvested pseudopodia with differential gel electrophoresis and specific antibodies.Dysfunction of annexin A2 contributes to hyperglycaemia-induced loss of human endothelial cell surface fibrinolytic activityReciprocal regulation of annexin A2 and EGFR with Her-2 in Her-2 negative and herceptin-resistant breast cancerSecretory leukocyte protease inhibitor (SLPI) expression and tumor invasion in oral squamous cell carcinomaGene expression profile during chondrogenesis in human bone marrow derived mesenchymal stem cells using a cDNA microarray.ERG oncoprotein inhibits ANXA2 expression and function in prostate cancerUnder-expression of annexin A2 is associated with Kazakh's esophageal squamous cell carcinoma.Annexin A2 promotes glioma cell invasion and tumor progressionClathrin mediates endocytosis of progastrin and activates MAPKs: role of cell surface annexin A2.Role of Annexin-II in GI cancers: interaction with gastrins/progastrins.Progastrin overexpression imparts tumorigenic/metastatic potential to embryonic epithelial cells: phenotypic differences between transformed and nontransformed stem cells.Upregulated expression of annexin II is a prognostic marker for patients with gastric cancer.Role of YAP and TAZ in pancreatic ductal adenocarcinoma and in stellate cells associated with cancer and chronic pancreatitisCharacterisation and protein expression profiling of annexins in colorectal cancer.Annexin A2 heterotetramer: structure and functionIncreased annexin A1 and A2 levels in bronchoalveolar lavage fluid are associated with resistance to respiratory disease in beef calves.Tyrosine 23 Phosphorylation of Annexin A2 Promotes Proliferation, Invasion, and Stat3 Phosphorylation in the Nucleus of Human Breast Cancer SK-BR-3 Cells.Annexin A2 is regulated by ovarian cancer-peritoneal cell interactions and promotes metastasis.Annexin II represents metastatic potential in clear-cell renal cell carcinoma.Annexin A2: its molecular regulation and cellular expression in cancer development.Annexin A2 complexes with S100 proteins: structure, function and pharmacological manipulation.The role of annexin A2 in tumorigenesis and cancer progressionProteins from formalin-fixed paraffin-embedded prostate cancer sections that predict the risk of metastatic disease.PRRX2 as a novel TGF-β-induced factor enhances invasion and migration in mammary epithelial cell and correlates with poor prognosis in breast cancer.Biological characteristics of a novel giant cell tumor cell line derived from spine.Annexin 2A sustains glioblastoma cell dissemination and proliferation.Cationic lipid guided short-hairpin RNA interference of annexin A2 attenuates tumor growth and metastasis in a mouse lung cancer stem cell modelProteomics-based analysis of invasion-related proteins in malignant gliomas.Clinical and prognostic role of annexin A2 in adamantinomatous craniopharyngioma.Annexin II/annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer.Annexin A2 is a molecular target for TM601, a peptide with tumor-targeting and anti-angiogenic effects.Annexin A2 regulates the levels of plasmin, S100A10 and Fascin in L5178Y cells.Interferon-gamma reduces cell surface expression of annexin 2 and suppresses the invasive capacity of prostate cancer cells.Glycosylation and annexin II cell surface translocation mediate airway epithelial wound repair.Tissue plasminogen activator induces pancreatic cancer cell proliferation by a non-catalytic mechanism that requires extracellular signal-regulated kinase 1/2 activation through epidermal growth factor receptor and annexin A2.Activation of the epidermal growth factor signalling pathway by tissue plasminogen activator in pancreas cancer cells.
P2860
Q26784418-E45C4E01-A3FD-4BA5-9F5D-1938007DF328Q26998741-84FC8F9B-4D05-407E-B661-EE16FEB30692Q27499827-A4991F81-A80F-443E-B72A-D6D38B2270F0Q30431185-3BBE5941-20EA-4329-973D-03F859CD9AB9Q31141815-C0D42398-A0A2-4FB5-8C95-E4670D44986EQ33789283-B3F5E938-1B61-48F0-904F-7AED49579721Q34408090-138CD3DB-8BF8-4928-8702-EF663176AC0CQ35071264-0F3643C0-7427-424C-AD3C-D2A152F8959CQ35072508-9EACD80E-7D78-4BA1-BFBF-A70F80AF228DQ35108911-15B20ECB-F8FB-4CF4-840C-B4E17C442448Q35131630-5F1F16DD-1F8B-486E-BF9D-11199C9B4B36Q35448499-32E66B6B-141C-4EC7-BB10-F58A66EBFB47Q35900882-9675B409-F411-47A3-8E00-5542ABC842E7Q35928337-03C631A0-06B2-4B92-9920-27BAB6194F25Q36131172-1940A50E-ECB5-4E73-89E5-A1AC1D48B8F1Q36207160-03495CFA-FE4B-4524-A43D-4A21002B0DD8Q36280897-D2D5220F-DC09-42D8-9F78-CAD79628EFCBQ36614738-2B016A8A-AAFF-4EBC-8EEE-16A4118D3606Q36790362-12AD45FA-3CF2-4D67-848B-B5C8B6D7A701Q36793848-0204E1B4-5628-468F-BFD5-A043DC7FE611Q36814450-5C3BC4A0-79F3-4CCF-8F74-7DB25F3B8EDCQ37207658-A0C5A9F2-5D00-40AD-A43C-1958AA7EA8CDQ37287432-1243B46A-522D-4D76-BE9D-A2A292744FDAQ37586765-4D1D271A-D586-48D0-B5AA-218D5740F1D0Q38258912-8CCFD1B6-40D6-400E-B5E1-50DF49AB1885Q38366258-73D01E6C-2011-4300-9C51-FDAD5DA02A30Q38384375-7CD40EB3-4F5B-4A6B-9AD0-6B74EC36F405Q38798369-EAD1BD8F-5FBA-4709-B070-31A4488A2F8DQ38800306-328089AA-D416-49A5-817A-256D3310889CQ38840667-857BA3F4-9D0D-479B-B0C9-965779019139Q39004813-A4358752-14D8-4D9A-8434-C5FB2E6469D5Q39250856-C117E2E4-E585-4123-B6B2-71625CB70B86Q39377574-F011007E-EAC4-4CD0-84BC-FCABCE185726Q39534721-1D494F60-5C91-4909-A5DD-EA1C6D8924E9Q39538754-7B32AADF-B90D-4015-9679-249AE6FB2A01Q39963945-BA342E18-959B-4052-B750-0ECE0D29D9EEQ40022007-234A1E7C-911D-4B8A-BDA2-0A9DA6EBBBAAQ40130532-993A1E80-D87B-482C-9BF9-8924BACB0598Q40141648-65E2F732-1FE6-4AE1-80DB-38E7AE6DEBF9Q40142332-64A31FEF-1043-41A7-A1AC-93998619B221
P2860
Specific interaction of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen and promotes invasion in vitro.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Specific interaction of tissue ...... nd promotes invasion in vitro.
@en
type
label
Specific interaction of tissue ...... nd promotes invasion in vitro.
@en
prefLabel
Specific interaction of tissue ...... nd promotes invasion in vitro.
@en
P2093
P2860
P356
P1433
P1476
Specific interaction of tissue ...... nd promotes invasion in vitro.
@en
P2093
P2860
P304
P356
10.1136/GUT.2003.026831
P407
P577
2004-07-01T00:00:00Z